Showing results (221-230 of 1,997) with videos related to

Sort By:
Pageof 200
Endocrine, Metabolic & Immune Disorders Drug Targets|May 9, 2022
Long-Lasting Effects of Spironolactone after its Withdrawal in Patients with Hyperandrogenic Skin DisordersChiara Sabbadin, Francesca Beggiao, Carlotta Keiko Vedolin, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|May 11, 2022
Betulinic Acid Exerts Anti-inflammatory Activity in Human Periodontal Ligament Cells Stimulated with Lipopolysaccharide and/or High GlucosePing Hu, Chunxia Zhu
Endocrine, Metabolic & Immune Disorders Drug Targets|June 18, 2021
Therapeutic Interventions of Novel SGLT2 Inhibitors Against Metabolic Disorders: Transforming the Association into PerspectivesKanwal Irshad, Muhammad Sajid Hamid Akash, Kanwal Rehman, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 21, 2020
Vitamin D Represses the Aggressive Potential of OsteosarcomaBehnoosh Tahbazlahafi, Malihe Paknejad, Shahnaz Khaghani, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 21, 2020
Tylophora hirsuta (Wall.) Extracts Ameliorate Diabetes Associated with Inflammation in Alloxan-induced Diabetic RatsFaisal Razzaque, Ali Sharif, Bushra Akhtar, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 22, 2020
VNTR Variant of the eNOS Gene and its Relationship with Osteoporosis in Postmenopausal Turkish WomenAyse F Nursal, Serbulent Yigit, Akin Tekcan, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 17, 2020
Platelet Count Improvement after Chronic Hepatitis C Treatment among Cirrhotic Patients Who Achieved Sustained Virological Response: Realworld Results from 2186 Patients in EgyptRehab Badawi, Shaimaa Soliman, Lobna Aboali, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 29, 2020
Prebiotic Carbohydrates for TherapeuticsRenuka Basavaiah, Prapulla S Gurudutt
Endocrine, Metabolic & Immune Disorders Drug Targets|December 15, 2020
Empagliflozin and the Diabetic Kidney: Pathophysiological Concepts and Future ChallengesGeorgios S Papaetis
Endocrine, Metabolic & Immune Disorders Drug Targets|November 27, 2020
Contribution of Rs780094 and Rs1260326 Polymorphisms in GCKR Gene to Non-alcoholic Fatty Liver Disease: A Meta-Analysis Involving 26,552 ParticipantsJiaying Li, Yuening Zhao, Hongxiang Zhang, et al.
Pageof 200